The European Scientific Working group on Influenza (ESWI) is looking forward to organizing the 7th edition of its ESWI Influenza Conferences in Valencia, Spain, on 13 – 16 September 2020. Over the past years, the ESWI Influenza Conferences have grown into the largest European scientific conferences dedicated to influenza. This edition also welcomes abstract submissions on RSV.
In keeping with its excellent scientific reputation, the upcoming seventh edition will give the floor to the most renowned influenza and RSV scientists, public health experts and healthcare professionals.
5 reasons to attend the seventh ESWI Influenza Conference
- Attendees will be offered a flexible programme with different sessions to choose from, covering topics from diagnostic approaches and mathematic modelling to healthcare policy and basic virology.
- An attractive programme of parallel sessions, keynote lectures, satellite symposia, plenary meetings and poster sessions covers all relevant scientific disciplines and focusses on new developments and state-of-the-art in the influenza and RSV fields.
- The conference will see a new edition of the Science Policy Interface track, a separate, tailor-made programme for public health officials and opinion leaders in healthcare work where experts will address some of the most intriguing issues, while distinguishing public health professionals will share their insights and expierience.
- Networking - the key to progress in science: interdisciplinary discussions inspire new ideas and new collaborations.
- Discover Valencia, Spain’s third-largest city, a captivating cultural mix of ultramodern architecture and mediaeval magic. And the birthplace of the iconic Spanish dish, paella.
The seventh ESWI Influenza Conference is hosted by
Eswi's partner organizations
Why should influenza and RSV experts meet?
1. From a clinical perspective
- Influenza and RSV cause very similar respiratory disease
- Influenza and RSV hit the extremes of age the hardest (children and the elderly)
2. From a pathogenesis perspective
- Clear overlaps as well as clear differences
- Resulting in major implications for intervention strategies
3. From an intervention strategies perspective (vaccines, antivirals and biological response modifiers)
- Intervention strategies for influenza are improving and emerging
- New intervention strategies for RSV are emerging
- Prospects for:
- Combined diagnostics/hospital management strategies
- Combined vaccination strategies
- Biological response modifiers: similar pathogeneses resulting in similar approaches
4. From a policy perspective
- Reimbursement policies for both influenza and RSV intervention strategies are crucial